PT - JOURNAL ARTICLE AU - Ana I. Bento AU - Rahil Taujale AU - Corrie Schot AU - Thijs Bosch AU - Rob Mariman AU - Aaron A. King AU - Pejman Rohani TI - Phylodynamics of pertussis in the vaccine era: transition to re-emergence AID - 10.1101/19012138 DP - 2019 Jan 01 TA - medRxiv PG - 19012138 4099 - http://medrxiv.org/content/early/2019/11/25/19012138.short 4100 - http://medrxiv.org/content/early/2019/11/25/19012138.full AB - Bordetella pertussis causes whooping cough in humans. Despite high routine vaccination coverage, pertussis has become the most prevalent vaccine-preventable disease in many industrialized countries, since the 1990s. While a plethora of candidate explanations for the resurgence remain hotly debated, two prevailing ideas focus on vaccine driven pathogen adaptation and on the switch to the latest generation vaccines. We use a suite of genomic and epidemiological approaches to characterize pertussis transmission in the Netherlands, between 1949 and 2017, investigate drivers of B. pertussis population diversity, and the role of allele shifts in the resurgence. Reconciling the epidemiological data with sequence data has allowed us to characterize a resurgence that is not accompanied with increased transmission but has unique functional genomic signatures of decreased diversity. Here we show a positive association between genetic diversity and incidence which validates the hypothesis that the resurgence is associated with the expansion of more pathogenic strains. We see a direct effect of vaccination on the replicative fitness of pathogens. Our models suggest, large outbreaks are unlikely to be due to immune evasion and the vaccine switch cannot be contributing to increased pertussis incidence. Therefore, efforts aimed at mitigating the resurgence in the population at large, and particularly in vulnerable infants, are more likely to succeed by maintaining routine vaccine coverage high.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trialsFunding StatementNIH grant fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data at this point is available upon request https://www.anabento.io